医学
疾病
流行病学
痴呆
民族
公共卫生
人口
老年学
环境卫生
因果关系(物理学)
帕金森病
病理
人类学
量子力学
物理
社会学
作者
Yoav Ben‐Shlomo,Sirwan K.L. Darweesh,Jorge J. Llibre‐Guerra,Connie Marras,Marta San Luciano,Caroline M. Tanner
出处
期刊:The Lancet
[Elsevier]
日期:2024-01-01
卷期号:403 (10423): 283-292
被引量:152
标识
DOI:10.1016/s0140-6736(23)01419-8
摘要
Summary
The epidemiology of Parkinson's disease shows marked variations in time, geography, ethnicity, age, and sex. Internationally, prevalence has increased over and above demographic changes. There are several potential reasons for this increase, including the decline in other competing causes of death. Whether incidence is increasing, especially in women or in many low-income and middle-income countries where there is a shortage of high-quality data, is less certain. Parkinson's disease is more common in older people and men, and a variety of environmental factors have been suggested to explain why, including exposure to neurotoxic agents. Within countries, there appear to be ethnic differences in disease risk, although these differences might reflect differential access to health care. The cause of Parkinson's disease is multifactorial, and involves genetic and environmental factors. Both risk factors (eg, pesticides) and protective factors (eg, physical activity and tendency to smoke) have been postulated to have a role in Parkinson's disease, although elucidating causality is complicated by the long prodromal period. Following the establishment of public health strategies to prevent cardiovascular diseases and some cancers, chronic neurodegenerative diseases such as Parkinson's disease and dementia are gaining a deserved higher priority. Multipronged prevention strategies are required that tackle population-based primary prevention, high-risk targeted secondary prevention, and Parkinson's disease-modifying therapies for tertiary prevention. Future international collaborations will be required to triangulate evidence from basic, applied, and epidemiological research, thereby enhancing the understanding and prevention of Parkinson's disease at a global level.
科研通智能强力驱动
Strongly Powered by AbleSci AI